In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 834 for your search:
Cancer Type/Condition:  Prostate cancer
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 60 to 90
Sponsor: Other
Protocol IDs: HP 7-251 S, NCT00524823

2.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 40 to 69
Sponsor: Other
Protocol IDs: STAF001982HU, NCT00906269

3.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: ROI10-352, R01CA138627, NCT01296672

4.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-022, NCT01352598

5.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: Thin-1, NCT01379742

6.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: CURC - FIT-0002, NCT01512472

7.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: R12038, NCT01571544

8.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: R12-3104L, NCT01581749

9.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 30 to 90
Sponsor: Other
Protocol IDs: UPCC 15810, NCT01661166

10.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A-38-52014-194, NCT01753297

11.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KEK-ZH-NR:2010-0004/0, NCT01770340

12.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VESI-12J03, NCT01777217

13.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230B2412, NCT01794793

14.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EGD-EC-005, 2012-000101-69, NCT01933022

15.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CR2P01127, DRKS00005263, NCT01950871

16.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9785-CL-0403, 2013-003022-92, U1111-1157-0224, NCT01977651

17.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MDV3100-10, NCT01995513

18.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: EC/2013/472, 2013-000782-36, NCT02001857

19.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CABAZL06499, U1111-1131-3161, NCT02074137

20.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: kk2013 MRI, NCT02102646

21.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9785-CL-0410, 2013-002271-17, NCT02116582

22.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 20 to 70
Sponsor: Other
Protocol IDs: 3-2013-0098, NCT02149628

23.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CDR0000455008, MRC-STAMPEDE, EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476

24.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: MG2009_01, NCT01006395

25.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Active
Age: 18 to 95
Sponsor: Other
Protocol IDs: IRB00057680, 1R01CA169188-01, NCT01666808
1     
New Search